Related Experiment Video
Updated: Jul 26, 2025
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
Protocol for preparing dynamic covalent macrocycles for co-delivering genes and drugs to cancer cell lines
Yonglei Lyu1, Xiaoxia Wu2, Jinghui Yang1
1MediCity Research Laboratory, University of Turku, 20520 Turku, Finland; Department of Chemistry, University of Turku, 20500 Turku, Finland.
Abstract:
Combination therapy using effective drug molecules and functional genes such as small interfering RNA (siRNA) has been suggested as a powerful strategy against multiple drug resistance. Here, we present a protocol for preparing a delivery system by developing dynamic covalent macrocycles using a dithiol monomer to co-deliver doxorubicin and siRNA. We describe steps for preparing the dithiol monomer, followed by co-delivery to form nanoparticles. We then detail procedures for cell uptake and assessing enhanced anti-cancer efficacy in vitro. For complete details on the use and execution of this protocol, please refer to Lyu et al.1.
Insights
This study introduces a novel nanoparticle system for co-delivering doxorubicin and small interfering RNA (siRNA) to combat drug-resistant cancers. The dynamic covalent macrocycle delivery enhances anti-cancer efficacy in vitro.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Multiple drug resistance (MDR) in cancer poses a significant therapeutic challenge.
- Combination therapy with drugs and functional genes like small interfering RNA (siRNA) is a promising strategy against MDR.
- Effective delivery systems are crucial for co-delivering multiple therapeutic agents.
Purpose of the Study:
- To develop a novel dynamic covalent macrocycle-based delivery system for co-delivering doxorubicin and siRNA.
- To create a protocol for preparing and utilizing these nanoparticles for enhanced cancer treatment.
- To evaluate the in vitro anti-cancer efficacy of this combination therapy.
Main Methods:
- Synthesis of a dithiol monomer for dynamic covalent macrocycle formation.
- Self-assembly of the macrocycles into nanoparticles for co-delivery of doxorubicin and siRNA.
- In vitro assessment of nanoparticle cellular uptake and anti-cancer effects.
Main Results:
- Successful preparation of a dynamic covalent macrocycle system capable of co-delivering doxorubicin and siRNA.
- Demonstration of efficient cellular uptake of the nanoparticles.
- Significant enhancement of anti-cancer efficacy in vitro compared to single-agent delivery.
Conclusions:
- The developed dynamic covalent macrocycle nanoparticles represent an effective strategy for co-delivery of doxorubicin and siRNA.
- This approach shows potential for overcoming multiple drug resistance in cancer treatment.
- The protocol provides a framework for developing advanced nanocarriers for combination cancer therapy.
